The DM Companion Logo The DM Companion
  • Home
  • Diagnosis
  • Rehab Plan
  • Home & Gear
  • Timeline & QoL
  • Research
  • Blog
Back to Blog Hub

Decoding the SOD1 DNA Test: What DNA Results Really Mean

July 9, 2026 Diagnosis & Science
Clinical glowing DNA representation for canine DM genetics

One of the most important breakthroughs in canine neurology was the discovery of a mutation in the superoxide dismutase 1 (SOD1) gene that is highly linked to canine Degenerative Myelopathy. For German Shepherd breeders and owners, testing for this mutation has become a standard diagnostic tool. However, interpreting genetic results can be confusing.

1. The SOD1 Mutation Explained

The SOD1 gene is responsible for producing an enzyme that neutralizes dangerous free radicals in cells. When a mutation occurs, the enzyme folds incorrectly, forming toxic aggregates (clumps) inside the motor neurons of the spinal cord. Over time, these aggregates cause the neurons to degenerate, interrupting signals between the brain and the legs.

2. Understanding the Three Test Results

The DNA test evaluates the alleles (copies) of the SOD1 gene. Every dog inherits one allele from their mother and one from their father. Results are classified into three categories:

  • Normal / Clear (G/G): The dog has two normal copies of the SOD1 gene. They will not develop DM and cannot pass the mutation to their offspring.
  • Carrier (G/A): The dog has one normal allele and one mutated allele. Carriers are highly unlikely to develop clinical DM, but they will pass the mutated allele to approximately 50% of their puppies.
  • At-Risk / Homozygous Mutated (A/A): The dog has two copies of the mutated allele. They are genetic candidates for developing Degenerative Myelopathy later in life.

Clinical Genetics Citation

Awano, T., et al. (2009). Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences, 106(12), 4894-4899. This seminal paper established the links between SOD1-A/A genotypes and spinal cord pathology.

3. The Concept of Incomplete Penetrance

It is crucial to understand that an **"At-Risk" (A/A) result is not a medical guarantee of clinical diagnosis**. This is due to a genetic phenomenon called **incomplete penetrance**.

Some dogs with the A/A genotype live to be 14 or 15 years old without ever showing hind limb weakness. While they possess the genetic recipe for DM, environmental, dietary, or modifier gene factors prevent the disease from manifesting. However, an A/A result means they are highly vulnerable, and any signs of knuckling or swaying should be investigated by a veterinary neurologist.

4. What to Do with the Results?

If your GSD tests **At-Risk (A/A)**, do not panic. Instead, use this information to be proactive:

  • Focus heavily on weight management (keep them lean).
  • Implement a daily exercise routine (walking, swimming) to build a robust physical reserve before any symptoms develop.
  • Submit the results to the Orthopedic Foundation for Animals (OFA) database to contribute to scientific research on breed health.

The DM Companion

Providing GSD and dog owners with clinically referenced resources, structured home rehab strategies, and modern mobility advice to manage Degenerative Myelopathy.

Core Resource Hubs

  • Symptoms & Diagnosis
  • Physiotherapy & Rehab
  • Home Modifications & Carts
  • Progression & Euthanasia
  • Clinical Trials & Drugs

Free Guide Download

Download the full German Shepherd DM Owner's Guide PDF immediately.

© 2026 The DM Companion. All rights reserved.

About & Disclaimer Contact Us Privacy Policy Terms of Service

Veterinary Disclaimer: All clinical content is referenced. The information on this site is for educational and informational purposes only and does not replace professional veterinary advice, diagnosis, or treatment. Consult a specialist for specific cases.